The results suggest that the R-point-associated Arf-p53 pathway is abrogated with Runx3 inactivation and recovered with Runx3 restoration in lung cancer cells bearing a heterozygous oncogenic K-Ras mutation. This evidence concerns the gene KRAS and lung carcinoma.